BHG

Allocation of the company’s results and discharge from liability
The meeting resolved that no dividend shall be paid for the financial year 2023, and that the company’s result shall be carried forward.

Furthermore, the meeting resolved on discharge of the members of the board of directors and the managing director from liability for the financial year 2023.

Appointment of and fees payable to members of the board of directors and auditor
The meeting resolved that the board of directors shall consist of six members with no deputies. Christian Bubenheim, Joanna Hummel, Kristian Eikre, Mikael Olander, Negin Yeganegy and Pernille Fabricius were re-elected as members of the board of directors. Christian Bubenheim was re-elected chairman of the board.

Moreover, the meeting resolved on remuneration to the board of directors amounting to unchanged SEK 2,160,000 in total, whereby SEK 600,000 shall be distributed to the chairman of the board and SEK 300,000 to each of the other board members not employed by the company. In addition, SEK 120,000 shall be distributed to the chairman of the audit committee, SEK 60,000 to the other members of the audit committee not employed by the company, SEK 60,000 to the chairman of the remuneration committee and SEK 30,000 to the other members of the remuneration committee not employed by the company. Board member Kristian Eikre refrains from remuneration.

The meeting also resolved to re-elect Öhrlings PricewaterhouseCoopers AB as auditor. Remuneration to the auditor shall be paid in accordance with approved invoices within the auditor’s quotation.

Nomination committee and remuneration report
The meeting further resolved on nomination committee procedures in accordance with the proposal set forth in the notice convening the meeting. The meeting also resolved to approve the boards of directors’ remuneration report.

Issue authorization
The meeting further resolved, in accordance with the board’s proposal, to authorize the board, on one or several occasions and for the period up to the next annual general meeting, to resolve to issue new shares, with or without deviation from the shareholders’ pre-emptive rights. The total number of shares that may be issued under the authorization must not amount to more than 20 percent of the total number of shares outstanding in the company following exercise of the authorization. A new issue may be made with or without provisions concerning non-cash consideration, set-off or other provision.

The purpose of the authorization is to enable the company to, in accordance with the company’s established acquisition strategy, finance acquisitions with own shares and to provide the board of directors with increased flexibility in the work with the company’s capital structure. Issuances of new shares under the authorization shall be made on market terms and conditions.